This study identifies research trends and hotspots on the comorbidity between periodontitis and neurodegenerative diseases, incl. Alzheimer's.

The objective of this study was to assess the neuropsychological characteristics of individuals with early-onset Alzheimer's disease (EOAD), late-onset Alzheimer's disease (LOAD), and very-late-onset Alzheimer's disease (VLOAD). The findings indicate notable neuropsychological variations across different age groups, demonstrating a progressive decline in cognitive function with age rather than distinct clinical presentations.

This study supports SDGs 3, 6, and 14 by highlighting the importance of freshwater biodiversity for human and planetary health, and suggesting that local and regional efforts for monitoring and improving ecosystem health are essential for reversing the current crisis in this area.

Rare Disease Education:  Infantile Neuroaxonal Dystrophy

Editor: Kelsey LaFayette, DNP, RN, FNP-C

Rare Disease Education:  1p36 Deletion Syndrome

Editor: Kelsey LaFayette, DNP, RN, FNP-C

Rare Disease Education:  Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency

Editor: Kelsey LaFayette, DNP, RN, FNP-C

Rare Disease Education:  FOXG1 Syndrome

Editor: Kelsey LaFayette, DNP, RN, FNP-C

As we pass the halfway point for the SDGs, many of the goals are worryingly off track and progress on 85% of the target indicators has stalled or even reversed. Through our information, products and people, RELX remains committed to advancing the Goals. Here are some of the ways that we continue to support their achievement.

Access to information is critical in achieving the SDGs - empowering the public to make decisions, informing policy making and enabling effective implementation and monitoring. RELX businesses regularly produce and publish free to download reports and analytics that draw upon vast amounts of information and data in support of the SDGs. Explore some of the reports and tools developed to date.

This Article supports SDG 3 sequencing hepatitis C virus genomes in west Africa, showing the level of genotypic diversity and measuring the response to direct-acting antivirals.